EvlaBio
Z├╝rich
About EvlaBio
EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $24.6M
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: evlabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/evlabio-2221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.